 |
|
Discovery of new biological principle can give better cancer treatment
September 13, 2004Pioneering research on leukaemia cells can have identified their vulnerable spot. This new knowledge can now be used to produce more effective medicines.
A group of scientists at the University of Bergen and Haukeland University Hospital made a surprising discovery when they stimulated leukaemia cells with the growth hormone GM-CSF. The reaction of the cells surprised everyone and would seem to indicate that scientists in Bergen have uncovered a new biological principle and consequently, a new therapeutic goal.
"We shouted, and expected to get one reply, but what we got was a bellow from an entire football team," says Project Leader Bj'¸rn Tore Gjertsen, who was recently presented in the renowned American periodical Cell.
Hugely important discovery for cancer patients
Cell membranes contain receptors that are stimulated by a number of environmental factors, among them hormones. This starts a chain reaction between proteins that can in cancer cells result in increased production of substances that hamper necrocytosis (cell death) and encourage cancer. A mutation in receptor Flt3 and how this activates the chain reaction has previously been paid a lot of attention. In the tests carried out by Gjertsen and his fellow scientists, it was the GM-CSF receptor that captured their attention. Patients with Flt3 mutation showed an enormous reaction, in proteins that should in principle be normal. This indicates that the attack should be mounted here, if one is to find effective but gentle methods of cancer treatment.
"We have used tests from thirty patients with an acute type of spinal leukaemia. Compared to young people with lymphatic leukaemia, these patients have little chance of recovery. Life expectancy without treatment is about 2-3 months and only 20 percent are cured by chemotherapy. The study results can in principle also be applied to other types of cancer cells, so these results can prove to be of great importance for future cancer sufferers," says Gjertsen.
In this particular research project, Gjertsen has collaborated with colleagues from Stanford University and also several from the research milieu in Bergen, including Randi Hovland and Øystein Bruserud. With support from the cancer association, Bruserud has over the last twelve years, collected an invaluable bank of leukaemia tests. The Americans were contacted because they have developed a quick method for looking at the activation of proteins with the help of an antibody produced by mice.
"We have invaluable profiles that give us a comprehensive picture of what happens inside the cells. In spite of the huge amount of scientific research on cancer during the last ten years, there have been few important clinical results. This is mainly due to the fact that we have turned one stone at a time and studied the building blocks of the cancer cells individually. In system biology we try to look for patterns so that we can get a complete and realistic overall picture," says Gjertsen, "and adds that the use of cells collected from patients, and not static cell lines, can be the only way to get secure results."
The collaboration now continues with unabated strength, searching for energized key cancer proteins that lie under the signal line studied in the Cell article.
Research Council of Norway, The
Hugely important discovery for cancer patients
Cell membranes contain receptors that are stimulated by a number of environmental factors, among them hormones. This starts a chain reaction between proteins that can in cancer cells result in increased production of substances that hamper necrocytosis (cell death) and encourage cancer. A mutation in receptor Flt3 and how this activates the chain reaction has previously been paid a lot of attention. In the tests carried out by Gjertsen and his fellow scientists, it was the GM-CSF receptor that captured their attention. Patients with Flt3 mutation showed an enormous reaction, in proteins that should in principle be normal. This indicates that the attack should be mounted here, if one is to find effective but gentle methods of cancer treatment.
"We have used tests from thirty patients with an acute type of spinal leukaemia. Compared to young people with lymphatic leukaemia, these patients have little chance of recovery. Life expectancy without treatment is about 2-3 months and only 20 percent are cured by chemotherapy. The study results can in principle also be applied to other types of cancer cells, so these results can prove to be of great importance for future cancer sufferers," says Gjertsen.
In this particular research project, Gjertsen has collaborated with colleagues from Stanford University and also several from the research milieu in Bergen, including Randi Hovland and Øystein Bruserud. With support from the cancer association, Bruserud has over the last twelve years, collected an invaluable bank of leukaemia tests. The Americans were contacted because they have developed a quick method for looking at the activation of proteins with the help of an antibody produced by mice.
"We have invaluable profiles that give us a comprehensive picture of what happens inside the cells. In spite of the huge amount of scientific research on cancer during the last ten years, there have been few important clinical results. This is mainly due to the fact that we have turned one stone at a time and studied the building blocks of the cancer cells individually. In system biology we try to look for patterns so that we can get a complete and realistic overall picture," says Gjertsen, "and adds that the use of cells collected from patients, and not static cell lines, can be the only way to get secure results."
The collaboration now continues with unabated strength, searching for energized key cancer proteins that lie under the signal line studied in the Cell article.
Research Council of Norway, The
Cancer Cells Current Events and Cancer Cells News RSSTeam finds breast cancer gene linked to disease spread
A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death.
New hope for cancer comes straight from the heart
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the Proceedings of the National Academy of Sciences, researchers at the Johns Hopkins University School of Medicine now report that this same class of drugs may hold new promise as a treatment for cancer.
Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds
An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract.
Lung cancer cells activate inflammation to induce metastasis
A research team from the University of California, San Diego School of Medicine has identified a protein produced by cancerous lung epithelial cells that enhances metastasis by stimulating the activity of inflammatory cells.
Why prostate cancer patients fail hormone deprivation therapy
The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years.
Molecular imaging enables earlier, individualized treatment of thyroid cancer
In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.
Dormant cancer cells rely on cellular self-cannibalization to survive
A single tumor-suppressing gene is a key to understanding, and perhaps killing, dormant ovarian cancer cells that persist after initial treatment only to reawaken years later, researchers at The University of Texas M. D. Anderson Cancer Center report in the December Journal of Clinical Investigation.
UC Davis researchers find molecule that targets brain tumors
UC Davis Cancer Center researchers report today the discovery of a molecule that targets glioblastoma, a highly deadly form of cancer. The finding, which is published in the January 2009 issue of the European Journal of Nuclear Medicine and Molecular Imaging, provides hope for effectively treating an incurable cancer.
Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.
Molecular marker identifies normal stem cells as intestinal tumor source
Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether normal stem cells can give rise to tumors.
More Cancer Cells Current Events and Cancer Cells News Articles
 | One Renegade Cell: The Quest For The Origin Of Cancer (Science Masters) by Robert A. Weinberg One of the leading cancer researchers in the world, Robert A. Weinberg is perfectly suited to describe the search for cancer's origins from the early days of this century to the present. Presuming little knowledge of biology, he tells how a cancer-causing virus was first discovered in 1909, how the correlation was made between chemical carcinogens and cancer, and how oncogenes (the genes that can... |
 | The Biology of Cancer HB by Robert A. Weinberg The Biology of Cancer is a comprehensive, authoritative, up-to-date textbook written by a major researcher in the field. It clearly presents the principles of cancer biology in an organized and accessible fashion. The information unfolds through the presentation of key experiments which give readers a sense of discovery, and provides insights into the conceptual foundation underlying cancer... |
 | Cancer Stem Cells: Identification and Targets Because the concept and discoveries of cancer stem cells are relatively new, scientists and researchers need an introduction to this dynamic area. Cancer Stem Cells presents a consolidated account of the research done to date and recent progresses in the studies of cancer stem cells. Such a presentation facilitates a better understanding of and draws attention to stem cell and cancer biology -... |
 | Renal Cell Cancer: Diagnosis and Therapy Renal Cell Cancer: Diagnosis and Therapy covers a number of topics in the field of renal cell cancer ranging from diagnostics, cancer research, molecular biology, immunology and clinical management. It provides an overview of a significant amount of new information concerning epidemiology, molecular and immunologic characteristics and surgical therapy for patients with these tumors that has... |
 | Cancer Stem Cells: Novel Concepts and Prospects for Tumor Therapy (Ernst Schering Foundation Symposium Proceedings) Cancer stem cells werehave originally been identified in leukemia and later in several solid tumor types. They have very different properties from the bulk of the tumor, as they divide much more slowly and have very efficient drug- resistance mechanisms. Current treatments might largely spare cancer stem cells, thus leading to tumor recurrence and metastasis. The recent identification of growth... |
 | The Skin Cancer Answer: The Natural Treatment for Basal and Sqamous Cell Carcinomas and Keratoses by William I. Lane, Linda Comac A complete guide to the new vegetable-based skin cancer... |
 | The Society of Cells: Cancer and Control of Cell Proliferation by Pr Sonnenschein For more than 30 years, the majority of researchers has assumed quiescence to be the default state of all cells and so have provided cells in culture with 'growth factors' to stimulate them to proliferate. During this time, many putative growth factors have been identified and ever more complex mechanisms through which they could interact and stimulate cells have been proposed. However,... |
 | Introduction to the Cellular and Molecular Biology of Cancer This new edition o Introduction and Molecular Biology of Cancer provides a concise yet comprehensive overview of cancer biology, covering the current status of both research and treatment. For the student or new researcher the breadth of cancer research can appear daunting, yet a broad understanding is essential for translation of laboratory findings into the clinic. Within the broad scope of... |
| Genes and the Biology of Cancer (Scientific American Library) by Harold Varmus, Robert A. Weinberg | |
 | The Biological Basis of Cancer by Robert G. McKinnell, Ralph E. Parchment, Alan O. Perantoni, G. Barry Pierce, Ivan Damjanov After introducing students to the basic biological principles of cancer, this new updated edition of an established textbook progresses to the human dimensions of the disease by considering actual cases of cancer. Other chapters discuss cancer pathology, metastasis, carcinogenesis, genetics, oncogenes and tumor suppressors, epidemiology, and the biological basis of cancer treatment. Also included... |
| © 2009 BrightSurf.com |